Back to search results

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatitis, Chronic · Pancreatitis, Acute · Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Corey Kurek, B.S.) · Reid.Corey@mayo.edu · 507-255-0316
    Contact: Principal Investigator (Yogish C Kudva)

  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Shari Reynolds, BS, CCRP) · reynoldssl2@upmc.edu · 412-383-0570
    Contact: Principal Investigator (Dhiraj Yadav, MD, MPH)
    Frederico G.S. de Toledo, MD (Sub-investigator)
Study leads

  • Yogish Kudva

    Principal Investigator

    Mayo Clinic

View source on ClinicalTrials.gov(opens in a new tab)